VCEL Vericel Corporation
$43.27▲ +0.53%
Healthcare
Other
Volume 558.4K
Avg Volume (10D) 521.0K
Key Metrics & Fundamentals
Market Cap
$2.22B
P/E Ratio
92.1
Div Yield
0.00%
52W Range
28.95 - 49.32
% vs 50 MA
6.33%
% vs 200 MA
12.15%
RSI-14
64.3
MACD Histogram
+0.3700
Beta (1Y vs SPY)
0.73
Free Cash Flow
$14.26M
Gross Rev
$77.46M
Gross Profit
$56.40M
EBITDA
$5.99M
COGS
$21.06M
Operating Exp
$55.97M
Operating Income
$434,000
EBIT
$434,000
Pretax Income
$2.21M
Net Income
$2.21M
EPS (Diluted)
0.04
Price & Volume History
Loading chart…
Recent News
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
GlobeNewswire · Oct 22, 2026 8:30 AM ET
Truist Securities Adjusts Vericel Price Target to $52 From $58, Maintains Buy Rating
MT Newswires · Oct 14, 2026 8:23 AM ET
Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain
Simply Wall St. · Sep 26, 2026 6:06 PM ET
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
GlobeNewswire · Sep 8, 2026 8:30 AM ET
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 13, 2026 7:00 AM ET
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
IPO-Edge.com · Aug 3, 2026 10:55 AM ET
Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating
MT Newswires · Jul 31, 2026 8:05 AM ET
Vericel Q2 Earnings Call Highlights
MarketBeat · Jul 30, 2026 5:03 PM ET
Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates
Zacks · Jul 30, 2026 9:35 AM ET
Vericel Swings to Q2 Net Income, Revenue Rises; Full-Year 2026 Revenue Guidance Raised
MT Newswires · Jul 30, 2026 9:29 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VCEL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.